- Home
- UPS vs GILD Comparison
UPS vs GILD Comparison
Compare UPS & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPS
- GILD
- Stock Information
- Founded
- UPS 1907
- GILD 1987
- Country
- UPS United States
- GILD United States
- Employees
- UPS N/A
- GILD N/A
- Industry
- UPS Trucking Freight/Courier Services
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPS Industrials
- GILD Health Care
- Exchange
- UPS Nasdaq
- GILD Nasdaq
- Market Cap
- UPS 113.3B
- GILD 113.0B
- IPO Year
- UPS 1999
- GILD 1992
- Fundamental
- Price
- UPS $125.66
- GILD $92.57
- Analyst Decision
- UPS Buy
- GILD Buy
- Analyst Count
- UPS 23
- GILD 26
- Target Price
- UPS $150.77
- GILD $96.71
- AVG Volume (30 Days)
- UPS 5.0M
- GILD 7.6M
- Earning Date
- UPS 01-28-2025
- GILD 02-11-2025
- Dividend Yield
- UPS 5.19%
- GILD 3.33%
- EPS Growth
- UPS N/A
- GILD N/A
- EPS
- UPS 6.62
- GILD 0.10
- Revenue
- UPS $90,686,000,000.00
- GILD $28,299,000,000.00
- Revenue This Year
- UPS $1.17
- GILD $6.50
- Revenue Next Year
- UPS $4.02
- GILD $0.36
- P/E Ratio
- UPS $18.99
- GILD $915.61
- Revenue Growth
- UPS N/A
- GILD 3.31
- 52 Week Low
- UPS $122.01
- GILD $62.07
- 52 Week High
- UPS $161.48
- GILD $98.90
- Technical
- Relative Strength Index (RSI)
- UPS 40.65
- GILD 54.42
- Support Level
- UPS $127.58
- GILD $90.27
- Resistance Level
- UPS $130.30
- GILD $93.59
- Average True Range (ATR)
- UPS 2.69
- GILD 2.19
- MACD
- UPS -0.55
- GILD -0.17
- Stochastic Oscillator
- UPS 29.92
- GILD 62.18
About UPS United Parcel Service Inc.
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 64% of total revenue while international package makes up 20%. Air and ocean freight forwarding, truckload brokerage, and contract logistics make up the remainder. UPS is currently pursuing "strategic alternatives" for its truck brokerage unit, Coyote, which it acquired in 2015.
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).